TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

scPharmaceuticals Inc. (NASDAQ: SCPH) Investor Investigation Over Potential Violations Of Securities Laws Announced

  • Investors who purchased shares of scPharmaceuticals Inc. (NASDAQ: SCPH), have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
scPharmaceuticals Inc.
Security
NASDAQ: SCPH

Summary

An investigation on behalf of investors of scPharmaceuticals Inc. (NASDAQ: SCPH) shares over potential securities laws violations by scPharmaceuticals Inc. and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of scPharmaceuticals Inc. (NASDAQ: SCPH) concerning whether a series of statements by scPharmaceuticals Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Burlington, MA based scPharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. scPharmaceuticals Inc. went public in November 2017 and sold 6,400,000 shares of common stock at a public offering price of $14.00 per share, for gross proceeds of $89.6 million. Since then shares of scPharmaceuticals Inc. (NASDAQ: SCPH) declined to as low as $4.09 per share on October 23, 2018.

Start Monitoring Your Investments